Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,669.70
+21.75 (0.39%)
At close: Jul 10, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 665.53 billion as of July 13, 2026. Its market cap has increased by 16.40% in one year.
Market Cap
665.53B
Enterprise Value
641.37B
Revenue
147.12B
Ranking
n/a
PE Ratio
28.91
Stock Price
5,669.70
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 665.53B, an increase of 302.86%. That is a compound annual growth rate of 14.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 677.79B | 2.95% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.66T |
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.04T |
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |